With the development of value analysis committees, the business model for medical device sales has been evolving to meet the newfound needs and demands of hospital systems across the country. The ripple effect of COVID-19 has only amplified sales disruption, and in...
Supply chain inefficiencies are one of the largest costs in hospitals. A large portion of these inefficiencies stem from ineffectively measuring the medical device life cycle. Without proper knowledge and resources to support life cycle costs while evaluating...
As Value Analysis processes become standard features of hospitals across the country, it is important to evaluate the system in place at your hospital. Because GreenLight is deeply embedded in the Value Analysis process of hospitals nationwide, we have insight into...
As explained by Jeff Byers in his article on the future of hospital budgeting, there are many necessary changes to be made as we move into 2018. US hospitals and hospital systems must focus on timely issues such as social determinants to health, regulatory changes,...
Written by Matt Hunckler, CEO of Verge and Contributor of Forbes Magazine A lot has changed about medical device procurement since Austin Dirks, founder and CEO of GreenLight Medical, was a medical device sales rep. Back then, physicians held purchasing power at the...
